Encision (ECIA) Stock Price, News & Analysis

Company Overview

Encision, Inc. is a U.S.-based medical device company specializing in the development and commercialization of safety solutions for electrosurgery. Founded in the early 1990s, the company’s core mission is to reduce the risk of unintended thermal injuries during surgical procedures by controlling stray electrical current. Encision’s operations focus on research, design, and manufacturing of proprietary instruments and monitoring systems that integrate seamlessly with existing surgical equipment.

At the heart of Encision’s product offering is its Active Electrode Monitoring (AEM) platform. The AEM system continuously detects and senses stray currents that may otherwise escape from standard electrosurgical instruments. By automatically interrupting the electrical output when unsafe current paths are detected, AEM enhances patient safety without compromising surgical performance. Encision complements this technology with a range of insulated laparoscopic and open surgery instruments, cables, and accessories designed to work exclusively within the AEM ecosystem.

Encision markets its AEM-enabled instruments and supporting products directly to hospitals, ambulatory surgery centers, and distributor networks across the United States, Europe and select international territories. The company builds strategic partnerships with surgical device distributors and leverages a direct sales force to provide training, technical support and clinical education for surgeons and operating room personnel. This global footprint underscores Encision’s commitment to expanding awareness of electrosurgical safety and improving patient outcomes worldwide.

Intellectual property protection is a cornerstone of Encision’s business strategy. The company maintains a portfolio of patents covering its monitoring algorithms, instrument insulation techniques and connector designs. Encision’s headquarters and manufacturing facilities operate under stringent quality management systems compliant with U.S. Food and Drug Administration (FDA) regulations and international medical device standards. This regulatory focus and patent-backed innovation underscore the company’s role as a specialized provider of electrosurgical safety technology.

Key Stats

• Today's Range: $0.28 to $0.28
• 50-Day Range: $0.21 to $0.40
• 52-Week Range: $0.10 to $0.50
• Volume: N/A
• Average Volume: 1,674 shs
• Market Capitalization: $4.73 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ECIA Stock Analysis - Frequently Asked Questions

How have ECIA shares performed this year?

Encision's stock was trading at $0.45 at the beginning of the year. Since then, ECIA shares have decreased by 37.8% and is now trading at $0.28.

How were Encision's earnings last quarter?

Encision Inc. (OTCMKTS:ECIA) released its quarterly earnings data on Thursday, July, 10th. The medical device company reported ($0.01) earnings per share for the quarter. The medical device company earned $1.58 million during the quarter. Encision had a negative net margin of 4.34% and a negative trailing twelve-month return on equity of 16.99%.

How do I buy shares of Encision?

Shares of ECIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Encision own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Encision investors own include MGT Capital Investments (MGTI), Brainstorm Cell Therapeutics (BCLI), Aviat Networks (AVNW), Activision Blizzard (ATVI), ATI (ATI) and Digital Turbine (APPS).

Company Calendar

• Last Earnings: 7/10/2025
• Today: 10/18/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ECIA
• CIK: 930775
• Web: www.encision.com
• Phone: (303) 444-2600
• Fax: 303-444-2693
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$220 thousand
• Net Margins: -4.34%
• Pretax Margin: -4.34%
• Return on Equity: -16.99%
• Return on Assets: -7.45%

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 1.92
• Quick Ratio: 0.72

Sales & Book Value

• Annual Sales: $6.55 million
• Price / Sales: 0.72
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.14 per share
• Price / Book: 2.00

Miscellaneous

• Outstanding Shares: 16,880,000
• Free Float: 10,677,000
• Market Cap: $4.73 million
• Optionable: Not Optionable
• Beta: 0.78